Company / Goodwill
Axsome Therapeutics, Inc. Goodwill History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$12.0M
FY2025
5-year range
$10.3M / $12.0M
FY2022-FY2025
Trend
+0.0%
vs FY2024
Sector context
#60 of 74
Health Care
What the data says
Axsome Therapeutics, Inc.'s goodwill of $12M is lower than 81% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of +5.3%.
Remained stable around $12M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 74This company $12.0M Sector average $4.0B
▼
-99.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +5.3%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #60 out of 74 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.0M | +0.0% |
| FY2024 | $12.0M | +0.0% |
| FY2023 | $12.0M | +16.8% |
| FY2022 | $10.3M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026